|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.699
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.667
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.512
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.499
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.401
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.355
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902239 |
1 |
0.341
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.293
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.280
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.273
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902218 |
1 |
0.260
|
|
|
|
negative regulation of smooth muscle cell apoptotic process
|
GO:0034392 |
1 |
0.252
|
|
|
|
negative regulation of heart rate
|
GO:0010459 |
4 |
0.235
|
|
|
|
phospholipase c activating angiotensin activated signaling pathway
|
GO:0086097 |
1 |
0.234
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.234
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.226
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.209
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:1902219 |
1 |
0.203
|
|
|
|
angiotensin activated signaling pathway
|
GO:0038166 |
4 |
0.201
|
|
|
|
activation of janus kinase activity
|
GO:0042976 |
2 |
0.198
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.193
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.189
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.179
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.177
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.177
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.174
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.172
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.166
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.156
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.156
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.149
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.146
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.143
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.143
|
|
|
|
cellular response to osmotic stress
|
GO:0071470 |
7 |
0.127
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.118
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.117
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.116
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.110
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.109
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.109
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.109
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.107
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.107
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.105
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.105
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.105
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.101
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.100
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.100
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.099
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.098
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.097
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.097
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.096
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.095
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.093
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.092
|
|
|
|
negative regulation of peptidyl serine phosphorylation
|
GO:0033137 |
10 |
0.089
|
|
|
|
regulation of response to osmotic stress
|
GO:0047484 |
3 |
0.089
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.087
|
|
|
|
regulation of superoxide anion generation
|
GO:0032928 |
4 |
0.086
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.086
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.085
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.084
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.084
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.083
|
|
|
|
t cell migration
|
GO:0072678 |
19 |
0.077
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.075
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.073
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.072
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.069
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.067
|
|
|
|
vasodilation by angiotensin involved in regulation of systemic arterial blood pressure
|
GO:0002033 |
2 |
0.066
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.066
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.064
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.064
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.064
|
|
|
|
receptor recycling
|
GO:0001881 |
11 |
0.064
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.063
|
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.061
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.061
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.061
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.061
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.060
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.059
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.059
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.058
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.058
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.057
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.057
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.056
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.056
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.056
|
|
|
|
g protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger
|
GO:0007199 |
1 |
0.054
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.054
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.054
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.053
|
|
|
|
positive regulation of monooxygenase activity
|
GO:0032770 |
2 |
0.053
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.052
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.051
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.051
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.051
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.050
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.050
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.049
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.049
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.048
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.048
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.048
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.047
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.047
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.047
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.046
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.044
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.044
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.043
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.042
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.042
|
|
|
|
superoxide anion generation
|
GO:0042554 |
11 |
0.042
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.042
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.042
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.041
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.041
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.041
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.040
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.040
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.040
|
|
|
|
regulation of kidney size
|
GO:0035564 |
3 |
0.039
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.039
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.038
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
18 |
0.038
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.037
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.037
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.036
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.036
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.035
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.035
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.034
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.034
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.034
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.034
|
|
|
|
negative regulation of blood circulation
|
GO:1903523 |
15 |
0.033
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.033
|
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
4 |
0.033
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.032
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.032
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.032
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.031
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.031
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.031
|
|
|
|
muscle cell apoptotic process
|
GO:0010657 |
18 |
0.030
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.030
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.030
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.030
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.030
|
|
|
|
renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure
|
GO:0001999 |
6 |
0.030
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.029
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.029
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.029
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.027
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.026
|
|
|
|
regulation of muscle cell apoptotic process
|
GO:0010660 |
17 |
0.026
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.026
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.026
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.026
|
|
|
|
regulation of intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:1902253 |
13 |
0.026
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.026
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.026
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.026
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.025
|
|
|
|
regulation of receptor recycling
|
GO:0001919 |
8 |
0.025
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.025
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
23 |
0.025
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.025
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.025
|
|
|
|
drinking behavior
|
GO:0042756 |
5 |
0.025
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.025
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.025
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.024
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.024
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.024
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.024
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.024
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.024
|
|
|
|
positive regulation of cholesterol esterification
|
GO:0010873 |
1 |
0.024
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.023
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.023
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.023
|
|
|
|
lymphocyte migration
|
GO:0072676 |
26 |
0.023
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.023
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
6 |
0.023
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.022
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.022
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.022
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.022
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.022
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.022
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.022
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.022
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.022
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.022
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.022
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.022
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.021
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.021
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.021
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.021
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.021
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.021
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.021
|
|
|
|
regulation of oxidoreductase activity
|
GO:0051341 |
15 |
0.021
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.021
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.021
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.021
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.021
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.021
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.021
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.020
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.020
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.020
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.020
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.020
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.020
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.020
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.020
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.020
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.020
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.020
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.019
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.019
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.019
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.019
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.019
|
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.019
|
|
|
|
negative regulation of heart contraction
|
GO:0045822 |
11 |
0.019
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.019
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.019
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.019
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.018
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.018
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.018
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.018
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.018
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.018
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.018
|
|
|
|
lytic vacuole organization
|
GO:0080171 |
21 |
0.018
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.018
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.018
|
|
|
|
regulation of superoxide metabolic process
|
GO:0090322 |
8 |
0.018
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.018
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.018
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.018
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.018
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.018
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.017
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.017
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.017
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.017
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.017
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.017
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.017
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.017
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.017
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.017
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.017
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.017
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.017
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.017
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.017
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.017
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.017
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.017
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.017
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.017
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.017
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.017
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.017
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.017
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.016
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.016
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.016
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.016
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.016
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.016
|
|
|
|
regulation of blood volume by renin angiotensin
|
GO:0002016 |
7 |
0.016
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.016
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.016
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.016
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.016
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.016
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.016
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.016
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.016
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.016
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.016
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.016
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.016
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.016
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.015
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.015
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.015
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.015
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.015
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.015
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.015
|
|
|
|
regulation of nitric oxide synthase activity
|
GO:0050999 |
6 |
0.015
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.015
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.015
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.015
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.015
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.015
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.015
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.015
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.015
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.015
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.015
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.015
|
|
|
|
positive regulation of metanephros development
|
GO:0072216 |
9 |
0.015
|
|
|
|
cellular response to ketone
|
GO:1901655 |
12 |
0.014
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.014
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.014
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.014
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.014
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.014
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.014
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.014
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.014
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.014
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.014
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.014
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.014
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.014
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.014
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.014
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.014
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.014
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.014
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.014
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.014
|
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.014
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.014
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.014
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.013
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.013
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.013
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.013
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.013
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.013
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.013
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.013
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.013
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.013
|
|
|
|
cellular response to alcohol
|
GO:0097306 |
23 |
0.013
|
|
|
|
exploration behavior
|
GO:0035640 |
21 |
0.013
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.013
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.013
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.013
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.013
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.013
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.013
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.013
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.013
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.013
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.012
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.012
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.012
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.012
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.012
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.012
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.012
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.012
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.012
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.012
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.012
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.012
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.012
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.012
|
|
|
|
regulation of vasoconstriction
|
GO:0019229 |
14 |
0.012
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.012
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.012
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.012
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.012
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.012
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.012
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.012
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.012
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.012
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.012
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.012
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.012
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.012
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.012
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.012
|
|
|
|
renin secretion into blood stream
|
GO:0002001 |
5 |
0.012
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.012
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.012
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.012
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.011
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.011
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.011
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.011
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.011
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.011
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.011
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.011
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.011
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.011
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.011
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.011
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.011
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.011
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.011
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.011
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.011
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.011
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.011
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.011
|
|
|
|
brain renin angiotensin system
|
GO:0002035 |
5 |
0.011
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.011
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.011
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.011
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.011
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.011
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.011
|
|
|
|
positive regulation of nitric oxide synthase activity
|
GO:0051000 |
2 |
0.011
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.011
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.011
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.011
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.011
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.011
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.011
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.011
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.011
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.011
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.011
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.011
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.011
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
13 |
0.011
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.011
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.011
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.011
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.010
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.010
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.010
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.010
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.010
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.010
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.010
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.010
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.010
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.010
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.010
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.010
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.010
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.010
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.010
|
|
|
|
response to dexamethasone
|
GO:0071548 |
8 |
0.010
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.010
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.010
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.010
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.010
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.010
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.010
|
|
|
|
positive regulation of jak stat cascade
|
GO:0046427 |
22 |
0.010
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.010
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.010
|
|
